Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Amyris, Inc.
Type
Public (NASDAQ: AMRS)
Industry Renewable Fuels, Anti-Malaria, Renewable Chemicals, Renewable Products
Founded 2003
Headquarters Emeryville, California, USA
Key people
John Melo: CEO
Revenue Increase None
Number of employees
300 - 350
Website Amyris.com

Amyris is an integrated renewable products company providing sustainable alternatives to a broad range of petroleum-sourced products and rare materials. Amyris, in conjunction with various partners, is creating industrial scale supplies of vitamins, captive perfume molecules like Ambroxan, a patchouli substitute and Farnesene which can be used in tires, and lubricant, as well as their own beauty care product line using squalane, their substitute molecule for shark oil. Amyris uses its industrial synthetic biology platform to convert plant sugars into a variety of hydrocarbon molecules, flexible building blocks which can be used in a wide range of products. They do this by reengineering yeast so it can recreate complicated molecules. The time to market was reduced four fold after Amyris teamed with Darpa. Amyris is commercializing these products both as renewable ingredients in cosmetics, flavors, fragrances, polymers, lubricants and consumer products, and also as renewable diesel and jet fuels. Amyris Brasil S.A., a subsidiary of Amyris, oversees the establishment and expansion of Amyris’s production in Brazil. Amyris also has fuel distribution capabilities in the United States through its subsidiary, Amyris Fuels LLC. Founded in 2003 and headquartered in Emeryville, Ca, Amyris has raised over $120 million in equity funding to-date, including investments from Royal DSM, Total S.A., Khosla Ventures, Votorantim Novos Negócios, Kleiner Perkins Caufield & Byers, TPG Biotech, and DAG Ventures as well as DARPA. Amyris is opening two more plants in New Zealand and Korea in proximity to sustainable sugar cane crops.

The company went public on NASDAQ in October 2010 (AMRS) but as of January 2013, was trading at less than 30% of its initial offering price due to lack of commercial success in cost-effectively producing "drop in" synthetic transportation fuel, which was to be its initial, major focus. The firm has now focused its attention on higher-priced and higher-margin products that are not in the transportation fuel area

Amyris' technology platform, branded "No Compromise," is focused on providing high performance petroleum-alternatives, using sustainable feedstock such as sugarcane.

Amyris is establishing the partnerships and capabilities needed to bring the renewable diesel fuel to market. A few of these actions include:

Artemisinin is a compound naturally found in the Chinese Sweet Wormwood plant effective in the treatment of malaria. Its production is hampered by difficult climate and agricultural conditions. Institute for OneWorld Health received a grant from the Bill and Melinda Gates Foundation to develop and produce non-seasonal, high-quality, affordable artemisinin, and engaged Amyris Biotechnologies and Sanofi to assist on certain parts of the project, which is near completion, based on technology from UC Berkeley, NRC Canada, and other sources.

Investment goal date:
Dividends reinvested
Amyris, Inc. AMRS report Q3 2017
Period
Date
Adjusted Actuals EPS
GAAP EPS
Q1 2018
2018-05-10
--
--
Q4 2017
2018-03-06
--
--
Q4 2017
2018-03-05
--
--
Q3 2017
2017-11-14
0.0000
0.0000
Q3 2017
2017-11-06
--
--
Q2 2017
2017-08-10
-0.4600
-0.4400
Q1 2017
2017-05-15
-1.9500
-1.9500
Q4 2016
2017-03-02
-2.1000
-2.7000
Q3 2016
2016-11-02
-1.2000
-1.2000
Q2 2016
2016-08-04
-0.9000
-1.6500
Q1 2016
2016-05-10
-1.0500
-1.8000
Q4 2015
2016-03-09
-2.7000
-4.2000
Q3 2015
2015-11-05
-8.2500
-8.2500
Q2 2015
2015-08-06
-8.8500
-9.3000
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
BlackRock Fund Advisors
152447
BlackRock Inc.
193755
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
80300
CARL DOMINO INC
201925
FMR LLC
4137620
GEODE CAPITAL MANAGEMENT, LLC
588026
GROUP ONE TRADING, L.P.
188857
KBC Group NV
274813
NORTHERN TRUST CORP
154105
SILVERBACK ASSET MANAGEMENT LLC
607387
TANAKA CAPITAL MANAGEMENT INC
2156762
TEMASEK HOLDINGS (PRIVATE) LTD
51828214
TPG Group Holdings (SBS) Advisors, Inc.
3978660
Vanguard Group, Inc
4419446
WOLVERINE ASSET MANAGEMENT LLC
1282051
Major Shareholders
Name Relationship
Total Shares
Holding stocks
DOERR L JOHN
7.2800% (5746558)
AMRS / GOOG / ZNGA /
CHUA NAM HAI DR
0.0100% (9000)
AMRS /
DUYK GEOFFREY M
0.0400% (29000)
AERI / AMRS / EPRS /
LEVINSON ARTHUR D
0.2800% (220864)
AAPL / AMRS /
MILLS STEVEN RICHARD
0.5000% (397435)
AMRS / BKH /
PICHETTE PATRICK
0.0300% (26000)
AMRS / GOOG /
Yang Patrick Y
0.0300% (24666)
AMRS / CDXS / CLDN / TSO /
Alexander Ralph
0.0300% (27186)
AMRS / EPE / SMRT /
Georgiadis Mary Margaret Hastings
0.0600% (47000)
AMRS / JNY / MAT / MCD /
Melo John
0.1200% (93948)
AMRS /
Melo John
0.1200% (94448)
AMRS /
Cherry Joel
0.0800% (61345)
AMRS /
Cherry Joel
1.1800% (929492)
AMRS /
Boisseau Philippe
0.0200% (17000)
AMRS /
Maxwell (Mauritius) Pte Ltd
62.7800% (49538771)
AMRS / PTLA /
Diniz Paulo Sergio de Oliveira
0.2900% (227000)
AMRS /
LOEB GARY
0.1800% (138389)
AKAO / AMRS /
MCFERSON SUSANNA
0.1800% (141841)
AMRS /
WEAVER KAREN
0.0100% (9102)
AMRS /
Khadder Nicholas
0.5100% (402020)
AMRS / FLDM /
ASADORIAN RAFFI
0.3100% (241648)
ACRX / AMRS /
VALIASEK KATHLEEN
0.3200% (251955)
AMRS /
DSM International B.V.
11.0100% (8684960)
AMRS /
KELSEY NICOLE
0.0300% (21000)
AMRS /
% ()